| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/27/2002 | EP0646180B1 Methods for inactivating nucleotide sequences and metal chelates for use therein |
| 02/27/2002 | EP0610448B1 Peptide library and screening method |
| 02/27/2002 | EP0442969B1 Wholly microfabricated biosensors and process for the manufacture and use thereof |
| 02/27/2002 | CN2479506Y Quantitative PCR gene magnification diagnostic instrument |
| 02/27/2002 | CN2479505Y Microbial teting box |
| 02/27/2002 | CN1338051A Assay for phosphatase-targeting toxins |
| 02/27/2002 | CN1338004A DNA sequencing method which employs various nucleotide mixture and kit used for the same |
| 02/27/2002 | CN1338003A Method and apparatus for measuring sample by luminescence |
| 02/27/2002 | CN1337580A Solid molecule operating method in microfluid system |
| 02/27/2002 | CN1337470A Non-coll DNA cloning identification method for wild mountain ginseng and cultivated ginseng |
| 02/27/2002 | CN1337469A Typing method of pig monosperm microsatellite DNA mark |
| 02/27/2002 | CN1337468A Method of preparing optimized high-density gene chip template |
| 02/27/2002 | CN1337463A Breeding of hepatitis A virus Chinese strain and attenuated strain and its complementary DNA sequence |
| 02/27/2002 | CN1337405A Sodium-ion drived chlorine-ion/exchange protein bicarbonate |
| 02/26/2002 | US6351712 Statistical combining of cell expression profiles |
| 02/26/2002 | US6350858 A polypeptide involved in controlling phosphate retention; diagnosis and therapy for chronic kidney failure, end stage kidney disease, uremic bone disease, and cancer |
| 02/26/2002 | US6350857 Fifty-four homologue (ffh) from streptococcus pneumoniae |
| 02/26/2002 | US6350854 Isolated 55 to 72 kDa protein which binds to prion proteins |
| 02/26/2002 | US6350853 Conjugated peptide nucleic acids having enhanced cellular uptake |
| 02/26/2002 | US6350730 OB polypeptides and modified forms as modulators of body weight |
| 02/26/2002 | US6350612 Cloned and sequenced eco ri fragment of bordetella pertussis chromosomal dna with 4696 base pairs containing genes which code for five subunits of pertussis toxin or fragments thereof containing at least one gene which codes for subunit of toxin |
| 02/26/2002 | US6350603 Phosphodiesterase 10 |
| 02/26/2002 | US6350601 Enzyme composition for use as a clinical diagnostic reagent |
| 02/26/2002 | US6350598 MurD |
| 02/26/2002 | US6350593 Receptors for fibroblast growth factors |
| 02/26/2002 | US6350592 Aortic-specific enhancer sequence and uses thereof |
| 02/26/2002 | US6350588 Detecting aeromonas, salmonella, escherchia or shigella in a single test medium by providing a medium of salt ions, chromogenic substrates that form color distinguishable components; inoculating the test medium and incubate; examine |
| 02/26/2002 | US6350587 Bacillus strain and antibiotic screening method |
| 02/26/2002 | US6350586 Method for isolating inhibitors of protease activity |
| 02/26/2002 | US6350585 2-chloro-4-nitrophenyl 4-o-beta-d-galactopyranosylmaltoside, an antibody inhibiting s-type amylase activity or p-type amylase activity, and thiocyanate as amylase activator; medical diagnosis |
| 02/26/2002 | US6350582 Hair analysis method |
| 02/26/2002 | US6350581 Tumor-associated antigen |
| 02/26/2002 | US6350580 Methods for detection of a target nucleic acid using a probe comprising secondary structure |
| 02/26/2002 | US6350579 Extended dynamic range assays |
| 02/26/2002 | US6350578 Method of quantitating dsDNA |
| 02/26/2002 | US6350576 Cancer detection probes |
| 02/26/2002 | US6350573 Contacting derivatized d1 protease substrate with d1 protease enzyme to form reaction mixture, derivatized d1 protease substrate comprising a fluorophore and a quenching moiety, incubating the reaction mixture |
| 02/26/2002 | US6350446 Polypeptides with amino acid sequences for kidney failure |
| 02/26/2002 | US6350368 Electrochemical and photochemical electrodes and their use |
| 02/26/2002 | CA2356396A1 Target enrichment and amplification for array analysis |
| 02/26/2002 | CA2079454C Steroid 5.alpha.-reductases |
| 02/24/2002 | WO2002012885A2 Simple methods for the drug monitoring of gpiib/iiia-receptor antagonists |
| 02/21/2002 | WO2002015158A1 Authentification method and device |
| 02/21/2002 | WO2002015107A2 Basecalling system and protocol |
| 02/21/2002 | WO2002015048A1 Method of detecting disease-associated snp |
| 02/21/2002 | WO2002014867A2 Ultra-sensitive detection systems |
| 02/21/2002 | WO2002014865A1 Methods and molecules useful for identifying molecules that bind lfa-1 and for determining receptor occupancy |
| 02/21/2002 | WO2002014862A2 Method and device for characterising and/or for detecting a bonding complex |
| 02/21/2002 | WO2002014858A2 Method for producing and identifying appropriate effectors of target molecules using substance libraries |
| 02/21/2002 | WO2002014857A2 Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen |
| 02/21/2002 | WO2002014830A2 Method of identification and quantification of biological molecules and apparatus therefore |
| 02/21/2002 | WO2002014559A2 High throughput screen for inhibitors of the folate biosynthetic pathway in bacteria |
| 02/21/2002 | WO2002014557A1 Diagnosis and treatment of tumor-suppressor associated disorders |
| 02/21/2002 | WO2002014555A2 Single-labeled oligonucleotide probes |
| 02/21/2002 | WO2002014554A2 The anti-neoplastic agent et-743 inhibits trans activation by sxr |
| 02/21/2002 | WO2002014553A2 A molecular vector identification system |
| 02/21/2002 | WO2002014552A2 Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease |
| 02/21/2002 | WO2002014551A2 Bioluminescent methods for direct visual detection of environmental compounds |
| 02/21/2002 | WO2002014547A2 Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders |
| 02/21/2002 | WO2002014546A1 Use of microbial dna sequences for the identification of human diseases |
| 02/21/2002 | WO2002014545A2 Method for determining weather a test compound binds to a large rna target |
| 02/21/2002 | WO2002014544A1 Method for determining genetic traits of improved breed animal embryos prior to implantation |
| 02/21/2002 | WO2002014542A2 Process for detecting serine/threonine kinase activity |
| 02/21/2002 | WO2002014538A2 Rational panel design method for microbiological investigations |
| 02/21/2002 | WO2002014536A2 Odulating multiple lineage kinase proteins |
| 02/21/2002 | WO2002014535A2 Electrochemical strip test for small volumes |
| 02/21/2002 | WO2002014534A2 Method of amplifying nucleic acids providing means for strand separation and universal sequence tags |
| 02/21/2002 | WO2002014533A2 Creatinine sensor calibration |
| 02/21/2002 | WO2002014522A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014500A2 Human genes and gene expression products |
| 02/21/2002 | WO2002014485A2 Kallikrein gene |
| 02/21/2002 | WO2002014476A2 Identifying and quantifying rnas and dnas associated with rna and dna binding proteins |
| 02/21/2002 | WO2002014467A2 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 02/21/2002 | WO2002014462A1 Biosensors and methods for their use |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014368A2 Proteins and nucleic acids encoding the same |
| 02/21/2002 | WO2002014361A2 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 02/21/2002 | WO2002014355A2 Novel mitogen activated kinase |
| 02/21/2002 | WO2002014348A2 Glycoproteins and methods of use thereof |
| 02/21/2002 | WO2002013845A2 Inflammation related g-protein coupled receptor |
| 02/21/2002 | WO2002013763A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | WO2002013686A1 Systems and methods for remote monitoring and modulation of medical devices |
| 02/21/2002 | WO2002013602A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function |
| 02/21/2002 | WO2001081608A3 Viral vectors for use in monitoring hiv drug resistance |
| 02/21/2002 | WO2001077149A3 Regulation of human cyslt2-like gpcr protein |
| 02/21/2002 | WO2001077140A3 Measurement of nutrient uptake in cells and methods based thereon |
| 02/21/2002 | WO2001074978A3 Lubricant compositions containing ester-substituted hindered phenol antioxidants |
| 02/21/2002 | WO2001072977A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001068899A3 Molecular weight markers for western blot |
| 02/21/2002 | WO2001066747A8 Proteins named fctrx and nucleic acids encoding same |
| 02/21/2002 | WO2001066597A3 Inflammation-related gene |
| 02/21/2002 | WO2001060856A3 Vmglom gene and its mutations causing disorders with a vascular component |
| 02/21/2002 | WO2001059110A3 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001057264A3 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes |
| 02/21/2002 | WO2001057198A3 Methods of generating protein expression arrays and the use thereof in rapid screening |
| 02/21/2002 | WO2001055391A3 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001055319A3 Endocrine related nucleic acids, proteins and antibodies |
| 02/21/2002 | WO2001053532A3 Barcoded synthetic lethal screening to identify drug targets |